1 Min Read
May 19 (Reuters) - Laurus Labs Ltd
* says API facility of unit 2 completed successful usfda inspection without any 483, formulations unit in same facility received EIR Source text - (bit.ly/2qZKKt9) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.